quinoxalines has been researched along with incb-018424 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baur, EM; Gschwend, JE; Hindupur, SV; Holm, PS; Horn, T; Koch, JA; Nawroth, R; Schmid, SC; Slotta-Huspenina, J; Wang, D; Youssef, A | 1 |
1 other study(ies) available for quinoxalines and incb-018424
Article | Year |
---|---|
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Combined Modality Therapy; Cyclic S-Oxides; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Humans; Hydroxybenzoates; Janus Kinases; Nitriles; Nitrofurans; Oncolytic Virotherapy; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinoxalines; STAT3 Transcription Factor; STAT6 Transcription Factor; Urinary Bladder Neoplasms | 2020 |